Growth/differentiation factor 5 protects nigrostriatal dopaminergic neurones in a rat model of Parkinson's disease

Neuroscience Letters

Volumn 233, Issue 2-3, 1997, Pages 73-76

  Sullivan, Aideen M ^a   Opacka Juffry, Jolanta ^a   Hötten, Gertrud ^b   Pohl, Jens ^b   Blunt, Stavia B ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b Biopharm GmbH   (Germany)

Author keywords

6 Hydroxydopamine; Dopamine; Growth differentiation factor 5; Neuroprotection; Nigrostriatal lesion; Parkinson's disease; Positron emission tomography

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; DRUG EFFECT; GROWTH REGULATION; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEUROPROTECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BONE MORPHOGENETIC PROTEINS; CORPUS STRIATUM; DOPAMINE; GROWTH SUBSTANCES; HOMOVANILLIC ACID; INJECTIONS, INTRAVENTRICULAR; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; RATS; RECOMBINANT PROTEINS; SUBSTANTIA NIGRA; TRANSFORMING GROWTH FACTOR BETA;

EID: 0343683400     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00623-X     Document Type: Article

References (19)

1. Beck, K.D., Valverde, J., Alexi, T., Poulsen, K., Moffat, B., Vandlen, R.A., Rosenthal, A. and Hefti, F., Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain, Nature, 373 (1995) 339-341.
2. Bloomfield, P.M., Myers, R., Hume, S.P., Spinks, T.J., Lammertsma, A.A. and Jones, T., Three-dimensional performance of a small-diameter positron emission tomograph, Phys. Med. Biol., 42 (1997) 389-400.
3. Bloomfield, P.M., Rajeswaran, S., Spinks, T.J., Hume, S.P., Myers, R., Ashworth, S., Clifford, K.M., Jones, W.F., Byars, L.G., Young, J., Andreaco, M., Williams, C.W., Lammertsma, A.A. and Jones, T., The design and physical characteristics of a small animal positron emission tomograph, Phys. Med. Biol., 40 (1995) 1105-1126.
4. Hoffer, B.J., Hoffman, A., Bowenkamp, K., Huettl, P., Hudson, J., Martin, D., Lin, L.-F.H. and Gerhardt, G.A., Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo, Neurosci. Lett., 182 (1994) 107-111.
5. Hotten, G., Neidhardt, H., Jacobowsky, B. and Pohl, J., Cloning and expression of recombinant human growth/differentiation factor 5, Biochem. Biophys. Res. Commun., 204 (1994) 646-652.
6. Hume, S.P., Myers, R., Bloomfield, P.M., Opacka-Juffry, J., Cremer, J.E., Ahier, R.G., Luthra, S.J., Brooks, D.J. and Lammertsma, A.A., Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography, Synapse, 12 (1992) 47-54.
7. 11C]RTI-121 as a selective radioligand for PET studies of the dopamine transporter, Nucl. Med. Biol., 23 (1996) 377-384.
8. Krieglstein, K., Suter-Crazzolara, C., Hotten, G., Pohl, J. and Unsicker, K., Trophic and protective effects of growth/differentiation factor 5, a member of the transforming growth factor-β superfamily, on midbrain dopaminergic neurons, J. Neurosci. Res., 42 (1995) 724-732.
9. Lin, L.-F.H., Doherty, D.H., Lile, J.D., Bektesh, S. and Collins, F., GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons, Science, 260 (1993) 1130-1132.
10. Opacka-Juffry, J., Ahier, R.G. and Cremer, J.E., Nomifensine-induced increase in extracellular striatal dopamine is enhanced by isoflurane anaesthesia, Synapse, 7 (1991) 169-171.
11. Opacka-Juffry, J., Ashworth, S., Hume, S.P., Martin, D., Brooks, D.J. and Blunt, S.B., GDNF protects against 6-OHDA nigrostriatal lesion: in vivo study with microdialysis and PET, NeuroReport, 7 (1995) 348-352.
12. Partridge, N.C., Alcorn, D., Michelangeli, V.P., Kemp, B.E., Ryan, G.B. and Martin, T.J., Functional properties of hormonally responsive cultured and malignant rat osteoblastic cells, Endocrinology, 108 (1981) 213-219.
13. Pellegrino, L.J., Pellegrino, A.S. and Cushman, A.J., A Stereotaxic Atlas of the Rat Brain, Plenum Press, New York, 1979.
14. Poulsen, K.T., Armanini, M.P., Klein, R.D., Hynes, M.A., Phillips, H.S. and Rosanthal, A., TGFβ2 and TGFβ3 are potent survival factors for midbrain dopaminergic neurons, Neuron, 13 (1994) 1245-1252.
15. Robb, R.A. and Hansen, D.P., A software system for interactive and quantitative visualization of multidimensional biomedical images, Aust. Phys. Eng. Sci., 14 (1991) 9-30.
16. Storm, E.E., Huynh, T.V., Copeland, N.G., Jenkin, N.A., Kingsley, D.M. and Lee, S.-J., Limb alterations in bradypodism mice due to mutations in a new member of the TGFβ-superfamily, Nature, 368 (1994) 639-643.
17. Tomac, A., Lindqvist, E., Lin, L.-F.H., Ogren, S.O., Young, D., Hoffer, B.J. and Olson, L., Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo, Nature, 373 (1995) 335-339.
18. Ungerstedt, U. and Arbuthnott, G.W., Quantitative recording of rotational behaviour in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system, Brain. Res., 24 (1970) 485-493.
19. Yamaguchi, A., Katagiri, T., Ikeda, T., Wozney, J.M., Rosen, V., Wang, E.A., Kahn, A.J., Suda, T. and Yoshiki, S., Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro, J. Cell Biol., 113 (1991) 681-687.